Clinical Trial Update: Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermatoses of the Hand [Phase 2]

View source ↗

Summary

Phase 2 trial comparing topical psoralen plus UVA (PUVA) versus narrow-band UVB for recalcitrant hand dermatoses in vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Psoralen topical (methoxsalen)

Snippet

Sponsor: University of British Columbia | Conditions: Vitiligo | Phase 2 | Status: UNKNOWN